Brief: Anika Therapeutics Q3 Revenue USD 41.465 Million
Nov 02 (Reuters) - Anika Therapeutics Q3 gross profit USD 24.944 million. * Q3 income from operations USD -7.674 million * Q3 net income USD -6.576 million * Q3 pretax profit USD -7.039 million
Nov 02 (Reuters) - Anika Therapeutics Q3 gross profit USD 24.944 million. * Q3 income from operations USD -7.674 million * Q3 net income USD -6.576 million * Q3 pretax profit USD -7.039 million